56 results
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
product or other factors beyond our control. For example, the market for our products was adversely affected by the COVID-19 pandemic. See “Risks … Related to Our Business and Strategy — The COVID-19 pandemic has had, and may continue to have, a significant adverse impact on our commercial operations
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
pandemic. See “Risks Related to Our Business and Strategy — The COVID-19 pandemic has had, and may continue to have, a significant adverse impact … . Like many companies, we have experienced an increased level of employee attrition since the COVID-19 pandemic. We have various programs designed
S-1
zmg4c
13 Dec 23
IPO registration
5:30pm
8-K
EX-99.1
tw6awh9q p5zpy
13 Dec 23
December 2023 Company Presentation
5:05pm
8-K
EX-99.1
ld77q0
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
SD
EX-1.01
iu4air
31 May 23
Conflict minerals disclosure
4:10pm
8-K
EX-99.1
8muj85
29 Mar 23
Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results
4:21pm
8-K
EX-99.2
qzqu9jchnp1r
15 Nov 22
Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
4:49pm
8-K
EX-99.1
u4ur4zi2
15 Nov 22
Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
4:49pm
424B5
9wyhpgnaf0cp d55x2a
22 Aug 22
Prospectus supplement for primary offering
4:11pm
424B5
jn3s42 pglo7pbnbzi
17 Aug 22
Prospectus supplement for primary offering
6:13pm